Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure

American Heart Association, 2002 Cohn, 1984, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure, N Engl J Med, 311, 819, 10.1056/NEJM198409273111303 Vinson, 1990, Early readmission of elderly patients with heart failure, J Am Geriatr Soc, 38, 1290, 10.1111/j.1532-5415.1990.tb03450.x Krumholz, 1997, Readmission after hospitalization for congestive heart failure among Medicare beneficiaries, Arch Intern Med, 157, 99, 10.1001/archinte.1997.00440220103013 Stevenson, 1989, The limited availability of physical signs for estimating hemodynamics in chronic heart failure, JAMA, 261, 884, 10.1001/jama.1989.03420060100040 Davie, 1996, Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction, BMJ, 312, 222, 10.1136/bmj.312.7025.222 Deveraux, 1987, Recommendations concerning use of echocardiography in hypertension and general population research, Hypertension, 9, 97 Henry, 1956, The possible role of cardiac stretch receptors in the induction of changes in urine flow, J Physiol, 131, 572, 10.1113/jphysiol.1956.sp005483 De Bold, 1981, A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats, Life Sci, 28, 89, 10.1016/0024-3205(81)90370-2 Kangawa, 1984, Purification and complete amino acid sequence of beta-rat atrial natriuretic polypeptide (beta-rANP) of 5000 daltons, Biochem Biophys Res Commun, 119, 933, 10.1016/0006-291X(84)90863-5 Sudoh, 1988, A new natriuretic peptide in porcine brain, Nature, 332, 78, 10.1038/332078a0 Sudoh, 1990, C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain, Biochem Biophys Res Commun, 168, 863, 10.1016/0006-291X(90)92401-K Minamino, 1991, Characterization of immunoreactive human C-type natriuretic peptide in brain and heart, Biochem Biophys Res Commun, 179, 535, 10.1016/0006-291X(91)91404-Z Hosoda, 1991, Expression of brain natriuretic peptide gene in human heart: Production in the ventricle, Hypertension, 17, 1152, 10.1161/01.HYP.17.6.1152 Klinge, 1998, An experimental study of cardiac natriuretic peptides as markers of development of heart failure, Scand J Clin Lab Invest, 58, 683, 10.1080/00365519850186120 Luchner, 1998, Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure, Am J Physiol, 274, H1684 Maeda, 1998, Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction, Am Heart J, 135, 825, 10.1016/S0002-8703(98)70041-9 Muders, 1997, Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction, Am Heart J, 134, 442, 10.1016/S0002-8703(97)70079-6 Yasue, 1994, Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects andpatients with heart failure, Circulation, 90, 195, 10.1161/01.CIR.90.1.195 Nagagawa, 1995, Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an “emergency” cardiac hormoneagainst ventricular overload, J Clin Invest, 96, 1280, 10.1172/JCI118162 Grantham, 1997, BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure, Am J Physiol, 92, R1077 Dao, 2001, Utility of B-type natriuretic peptide (BNP) in the diagnosis of heart failure in an urgent care setting, J Am Coll Cardiol, 37, 379, 10.1016/S0735-1097(00)01156-6 Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Wuerz, 1992, Effects of prehospital medications on mortality and length of stay in CHF, Ann Emerg Med, 21, 669, 10.1016/S0196-0644(05)82777-5 Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Morrison, 2002, Utility of rapid B-type natriuretic peptide in differentiating congestive heart failure from lung disease, J Am Coll Cardiol, 39, 202, 10.1016/S0735-1097(01)01744-2 Maisel, 2002, B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient, Rev Cardiovasc Med, 3, S10 Mueller, 2004, Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea, N Engl J Med, 350, 647, 10.1056/NEJMoa031681 McCullough, 2002, B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure, Circulation, 106, 416, 10.1161/01.CIR.0000025242.79963.4C Maisel, 2004, Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath, J Am Coll Cardiol, 44, 1328, 10.1016/j.jacc.2004.06.015 Harrison, 2002, B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea, Ann Emerg Med, 39, 131, 10.1067/mem.2002.121483 Wang, 2004, Plasma natriuretic peptide levels and the risk of cardiovascular events and death, N Engl J Med, 350, 655, 10.1056/NEJMoa031994 Atisha, 2004, A prospective study in search of an optimal BNP level to screen patients for cardiac dysfunction, Am Heart J, 148, 518, 10.1016/j.ahj.2004.03.014 Heidenreich, 2004, Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction, J Am Coll Cardiol, 43, 1019, 10.1016/j.jacc.2003.10.043 Berger, 2002, B-type natriuretic peptide predicts sudden death in patients with chronic heart failure, Circulation, 105, 2392, 10.1161/01.CIR.0000016642.15031.34 Hunt, 2001 Nohria, 2002, Medical management of advanced heart failure, JAMA, 287, 628, 10.1001/jama.287.5.628 Latini, 2002, Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: The Valsartan Heart Failure Trial (Val-HeFT), Circulation, 106, 2454, 10.1161/01.CIR.0000036747.68104.AC Richards, 1999, Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group, Circulation, 99, 786, 10.1161/01.CIR.99.6.786 Kawai, 2001, Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: A potential of hormone-guided treatment, Am Heart J, 141, 925, 10.1067/mhj.2001.115435 Cheng, 2001, A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure, J Am Coll Cardiol, 37, 386, 10.1016/S0735-1097(00)01157-8 Bettencourt, 2002, Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcomes after hospital discharge in patients with heart failure, Am J Med, 113, 215, 10.1016/S0002-9343(02)01184-1 Tung, 2004, Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock, Crit Care Med, 32, 1643, 10.1097/01.CCM.0000133694.28370.7F Kazanegra, 2001, A rapid assay for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilotstudy, J Card Fail, 7, 21, 10.1054/jcaf.2001.23355 Berman, 2002, B-type natriuretic peptide (BNP) levels in differentiating congestive heart failure from acute respiratory distress syndrome (ARDS), Circulation, 106, II Cleland, 1997, Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators, Eur Heart J., 18, 41, 10.1093/eurheartj/18.1.41 Troughton, 2000, Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations, Lancet, 355, 1126, 10.1016/S0140-6736(00)02060-2 Tsutamoto, 2001, Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure, J Am Coll Cardiol, 37, 1228, 10.1016/S0735-1097(01)01116-0 Anand, 2003, Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT), Circulation, 107, 1278, 10.1161/01.CIR.0000054164.99881.00 Lee, 2002, The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure, J Card Fail, 8, 149, 10.1054/jcaf.2002.125368 Bhalla, 2004, B-type natriuretic peptide: The level and the drug—partners in the diagnosis of congestive heart failure, Congest Heart Fail, 10, 3, 10.1111/j.1527-5299.2004.03310.x de Lemos, 2001, The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes, N Engl J Med, 345, 1014, 10.1056/NEJMoa011053 Sabatine, 2002, Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactiveprotein, and B-type natriuretic peptide, Circulation, 105, 1760, 10.1161/01.CIR.0000015464.18023.0A Morrow, 2003, Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18, J Am Coll Cardiol, 41, 1264, 10.1016/S0735-1097(03)00168-2 Jiang, 2004, Use of B-type natriuretic peptide in evaluation of early percutaneous coronary intervention in patients with acute coronary syndrome, Chin Med J (Engl), 117, 1130